APO Research, Inc.

APO RESEARCH · REPORT

Fosfomycin Calcium

Selected research

Market Structure

Global Fosfomycin Calcium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Fosfomycin Calcium market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Fosfomycin Calcium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Fosfomycin Calcium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Fosfomycin Calcium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Fosfomycin Calcium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Fosfomycin Calcium include Shanghai Xinya Pharmaceutical, Shanghai Wuzhou Pharmaceutical, Merck KGaA, Hubei Xunda Pharmaceutical, Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd., Guangxi Nanning Baihui Pharmaceutical, Shanxi Dongjin Pharmaceutical Co., Ltd., Shinpoong Pharm and Northeast Pharm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Fosfomycin Calcium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fosfomycin Calcium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fosfomycin Calcium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Fosfomycin Calcium market size, projected growth trends, production technologies, key applications, and end-use industries.

Fosfomycin Calcium Segment by Company

Shanghai Xinya Pharmaceutical

Shanghai Wuzhou Pharmaceutical

Merck KGaA

Hubei Xunda Pharmaceutical

Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.

Guangxi Nanning Baihui Pharmaceutical

Shanxi Dongjin Pharmaceutical Co., Ltd.

Shinpoong Pharm

Northeast Pharm

Manus Aktteva Biopharma LLP

FarmaSino Pharmaceutical

Ercros

Fosfomycin Calcium Segment by Type

Tablets

Injection

Fosfomycin Calcium Segment by Application

Medical

Microbiology

Others

Fosfomycin Calcium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fosfomycin Calcium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fosfomycin Calcium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fosfomycin Calcium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Fosfomycin Calcium market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Fosfomycin Calcium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Fosfomycin Calcium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Fosfomycin Calcium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Fosfomycin Calcium Industry Trends Table 2. Fosfomycin Calcium Industry Drivers Table 3. Fosfomycin Calcium Industry Opportunities and Challenges Table 4. Fosfomycin Calcium Industry Restraints Table 5. Global Fosfomycin Calcium Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Fosfomycin Calcium Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Fosfomycin Calcium Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Fosfomycin Calcium Sales Market Share by Manufacturers Table 9. Global Fosfomycin Calcium Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Fosfomycin Calcium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Fosfomycin Calcium Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Fosfomycin Calcium Manufacturers, Product Type & Application Table 13. Global Fosfomycin Calcium Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Fosfomycin Calcium by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablets Table 17. Major Manufacturers of Injection Table 18. Global Fosfomycin Calcium Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Fosfomycin Calcium Sales by Type (2021-2026) & (k units) Table 20. Global Fosfomycin Calcium Sales by Type (2027-2032) & (k units) Table 21. Global Fosfomycin Calcium Sales Market Share by Type (2021-2026) Table 22. Global Fosfomycin Calcium Sales Market Share by Type (2027-2032) Table 23. Global Fosfomycin Calcium Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Fosfomycin Calcium Revenue by Type (2021-2026) & (k units) Table 25. Global Fosfomycin Calcium Revenue by Type (2027-2032) & (k units) Table 26. Global Fosfomycin Calcium Revenue Market Share by Type (2021-2026) Table 27. Global Fosfomycin Calcium Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Medical Table 29. Major Manufacturers of Microbiology Table 30. Major Manufacturers of Others Table 31. Global Fosfomycin Calcium Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Fosfomycin Calcium Sales by Application (2021-2026) & (k units) Table 33. Global Fosfomycin Calcium Sales by Application (2027-2032) & (k units) Table 34. Global Fosfomycin Calcium Sales Market Share by Application (2021-2026) Table 35. Global Fosfomycin Calcium Sales Market Share by Application (2027-2032) Table 36. Global Fosfomycin Calcium Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Fosfomycin Calcium Revenue by Application (2021-2026) & (k units) Table 38. Global Fosfomycin Calcium Revenue by Application (2027-2032) & (k units) Table 39. Global Fosfomycin Calcium Revenue Market Share by Application (2021-2026) Table 40. Global Fosfomycin Calcium Revenue Market Share by Application (2027-2032) Table 41. Global Fosfomycin Calcium Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Fosfomycin Calcium Sales by Region (2021-2026) & (k units) Table 43. Global Fosfomycin Calcium Sales Market Share by Region (2021-2026) Table 44. Global Fosfomycin Calcium Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Fosfomycin Calcium Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Fosfomycin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Fosfomycin Calcium Sales by Country (2021-2026) & (k units) Table 48. North America Fosfomycin Calcium Sales by Country (2027-2032) & (k units) Table 49. Europe Fosfomycin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Fosfomycin Calcium Sales by Country (2021-2026) & (k units) Table 51. Europe Fosfomycin Calcium Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Fosfomycin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Fosfomycin Calcium Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Fosfomycin Calcium Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Fosfomycin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Fosfomycin Calcium Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Fosfomycin Calcium Sales by Country (2027-2032) & (k units) Table 58. Global Fosfomycin Calcium Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Fosfomycin Calcium Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Fosfomycin Calcium Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Fosfomycin Calcium Revenue Market Share by Region (2021-2026) Table 62. Global Fosfomycin Calcium Revenue Market Share by Region (2027-2032) Table 63. Shanghai Xinya Pharmaceutical Company Information Table 64. Shanghai Xinya Pharmaceutical Business Overview Table 65. Shanghai Xinya Pharmaceutical Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Shanghai Xinya Pharmaceutical Fosfomycin Calcium Product Portfolio Table 67. Shanghai Xinya Pharmaceutical Recent Development Table 68. Shanghai Wuzhou Pharmaceutical Company Information Table 69. Shanghai Wuzhou Pharmaceutical Business Overview Table 70. Shanghai Wuzhou Pharmaceutical Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Shanghai Wuzhou Pharmaceutical Fosfomycin Calcium Product Portfolio Table 72. Shanghai Wuzhou Pharmaceutical Recent Development Table 73. Merck KGaA Company Information Table 74. Merck KGaA Business Overview Table 75. Merck KGaA Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Merck KGaA Fosfomycin Calcium Product Portfolio Table 77. Merck KGaA Recent Development Table 78. Hubei Xunda Pharmaceutical Company Information Table 79. Hubei Xunda Pharmaceutical Business Overview Table 80. Hubei Xunda Pharmaceutical Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Hubei Xunda Pharmaceutical Fosfomycin Calcium Product Portfolio Table 82. Hubei Xunda Pharmaceutical Recent Development Table 83. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Company Information Table 84. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Business Overview Table 85. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Fosfomycin Calcium Product Portfolio Table 87. Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Recent Development Table 88. Guangxi Nanning Baihui Pharmaceutical Company Information Table 89. Guangxi Nanning Baihui Pharmaceutical Business Overview Table 90. Guangxi Nanning Baihui Pharmaceutical Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Guangxi Nanning Baihui Pharmaceutical Fosfomycin Calcium Product Portfolio Table 92. Guangxi Nanning Baihui Pharmaceutical Recent Development Table 93. Shanxi Dongjin Pharmaceutical Co., Ltd. Company Information Table 94. Shanxi Dongjin Pharmaceutical Co., Ltd. Business Overview Table 95. Shanxi Dongjin Pharmaceutical Co., Ltd. Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shanxi Dongjin Pharmaceutical Co., Ltd. Fosfomycin Calcium Product Portfolio Table 97. Shanxi Dongjin Pharmaceutical Co., Ltd. Recent Development Table 98. Shinpoong Pharm Company Information Table 99. Shinpoong Pharm Business Overview Table 100. Shinpoong Pharm Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Shinpoong Pharm Fosfomycin Calcium Product Portfolio Table 102. Shinpoong Pharm Recent Development Table 103. Northeast Pharm Company Information Table 104. Northeast Pharm Business Overview Table 105. Northeast Pharm Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Northeast Pharm Fosfomycin Calcium Product Portfolio Table 107. Northeast Pharm Recent Development Table 108. Manus Aktteva Biopharma LLP Company Information Table 109. Manus Aktteva Biopharma LLP Business Overview Table 110. Manus Aktteva Biopharma LLP Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Manus Aktteva Biopharma LLP Fosfomycin Calcium Product Portfolio Table 112. Manus Aktteva Biopharma LLP Recent Development Table 113. FarmaSino Pharmaceutical Company Information Table 114. FarmaSino Pharmaceutical Business Overview Table 115. FarmaSino Pharmaceutical Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. FarmaSino Pharmaceutical Fosfomycin Calcium Product Portfolio Table 117. FarmaSino Pharmaceutical Recent Development Table 118. Ercros Company Information Table 119. Ercros Business Overview Table 120. Ercros Fosfomycin Calcium Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Ercros Fosfomycin Calcium Product Portfolio Table 122. Ercros Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Fosfomycin Calcium Distributors List Table 126. Fosfomycin Calcium Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Fosfomycin Calcium Product Image Figure 2. Global Fosfomycin Calcium Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fosfomycin Calcium Market Size (2021-2032) & (US$ Million) Figure 4. Global Fosfomycin Calcium Sales (2021-2032) & (k units) Figure 5. Global Fosfomycin Calcium Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Fosfomycin Calcium Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablets Image Figure 9. Injection Image Figure 10. Global Fosfomycin Calcium Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Fosfomycin Calcium Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Fosfomycin Calcium Sales Market Share by Type (2021-2032) Figure 13. Global Fosfomycin Calcium Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Fosfomycin Calcium Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Fosfomycin Calcium Revenue Market Share by Type (2021-2032) Figure 16. Medical Image Figure 17. Microbiology Image Figure 18. Others Image Figure 19. Global Fosfomycin Calcium Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Fosfomycin Calcium Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Fosfomycin Calcium Sales Market Share by Application (2021-2032) Figure 22. Global Fosfomycin Calcium Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Fosfomycin Calcium Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Fosfomycin Calcium Revenue Market Share by Application (2021-2032) Figure 25. North America Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Fosfomycin Calcium Sales Market Share by Country (2021-2032) Figure 27. U.S. Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Fosfomycin Calcium Sales Market Share by Country (2021-2032) Figure 32. Germany Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Fosfomycin Calcium Sales Market Share by Country (2021-2032) Figure 39. China Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Fosfomycin Calcium Sales Market Share by Country (2021-2032) Figure 47. Brazil Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Fosfomycin Calcium Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Fosfomycin Calcium Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Fosfomycin Calcium Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Fosfomycin Calcium Revenue (2021-2032) & (US$ Million) Figure 58. North America Fosfomycin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Fosfomycin Calcium Revenue (2021-2032) & (US$ Million) Figure 60. Europe Fosfomycin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Fosfomycin Calcium Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Fosfomycin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Fosfomycin Calcium Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Fosfomycin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Fosfomycin Calcium Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Fosfomycin Calcium Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Injection
Applications
  • Medical
  • Microbiology
  • Others
Companies covered
  • Shanghai Xinya Pharmaceutical
  • Shanghai Wuzhou Pharmaceutical
  • Merck KGaA
  • Hubei Xunda Pharmaceutical
  • Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
  • Guangxi Nanning Baihui Pharmaceutical
  • Shanxi Dongjin Pharmaceutical Co., Ltd.
  • Shinpoong Pharm
  • Northeast Pharm
  • Manus Aktteva Biopharma LLP
  • FarmaSino Pharmaceutical
  • Ercros

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fosfomycin Calcium Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fosfomycin Calcium Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Fosfomycin Calcium Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Fosfomycin Calcium Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Fosfomycin Calcium Market Dynamics
  1. 2.1 Fosfomycin Calcium Industry Trends
  2. 2.2 Fosfomycin Calcium Industry Drivers
  3. 2.3 Fosfomycin Calcium Industry Opportunities and Challenges
  4. 2.4 Fosfomycin Calcium Industry Restraints
3 Fosfomycin Calcium Market by Manufacturers
  1. 3.1 Global Fosfomycin Calcium Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Fosfomycin Calcium Sales by Manufacturers (2021-2026)
  3. 3.3 Global Fosfomycin Calcium Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Fosfomycin Calcium Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Fosfomycin Calcium Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Fosfomycin Calcium Manufacturers, Product Type & Application
  7. 3.7 Global Fosfomycin Calcium Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Fosfomycin Calcium Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Fosfomycin Calcium Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Fosfomycin Calcium Tier 1, Tier 2, and Tier 3
4 Fosfomycin Calcium Market by Type
  1. 4.1 Fosfomycin Calcium Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Injection
  4. 4.2 Global Fosfomycin Calcium Sales by Type
  5. 4.2.1 Global Fosfomycin Calcium Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Fosfomycin Calcium Sales by Type (2021-2032)
  7. 4.2.3 Global Fosfomycin Calcium Sales Market Share by Type (2021-2032)
  8. 4.3 Global Fosfomycin Calcium Revenue by Type
  9. 4.3.1 Global Fosfomycin Calcium Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Fosfomycin Calcium Revenue by Type (2021-2032)
  11. 4.3.3 Global Fosfomycin Calcium Revenue Market Share by Type (2021-2032)
5 Fosfomycin Calcium Market by Application
  1. 5.1 Fosfomycin Calcium Application Introduction
  2. 5.1.1 Medical
  3. 5.1.2 Microbiology
  4. 5.1.3 Others
  5. 5.2 Global Fosfomycin Calcium Sales by Application
  6. 5.2.1 Global Fosfomycin Calcium Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fosfomycin Calcium Sales by Application (2021-2032)
  8. 5.2.3 Global Fosfomycin Calcium Sales Market Share by Application (2021-2032)
  9. 5.3 Global Fosfomycin Calcium Revenue by Application
  10. 5.3.1 Global Fosfomycin Calcium Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Fosfomycin Calcium Revenue by Application (2021-2032)
  12. 5.3.3 Global Fosfomycin Calcium Revenue Market Share by Application (2021-2032)
6 Global Fosfomycin Calcium Sales by Region
  1. 6.1 Global Fosfomycin Calcium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fosfomycin Calcium Sales by Region (2021-2032)
  3. 6.2.1 Global Fosfomycin Calcium Sales by Region (2021-2026)
  4. 6.2.2 Global Fosfomycin Calcium Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fosfomycin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Fosfomycin Calcium Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Fosfomycin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Fosfomycin Calcium Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Fosfomycin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Fosfomycin Calcium Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Fosfomycin Calcium Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Fosfomycin Calcium Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Fosfomycin Calcium Revenue by Region
  1. 7.1 Global Fosfomycin Calcium Revenue by Region
  2. 7.1.1 Global Fosfomycin Calcium Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Fosfomycin Calcium Revenue by Region (2021-2026)
  4. 7.1.3 Global Fosfomycin Calcium Revenue by Region (2027-2032)
  5. 7.1.4 Global Fosfomycin Calcium Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Fosfomycin Calcium Revenue (2021-2032)
  8. 7.2.2 North America Fosfomycin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Fosfomycin Calcium Revenue (2021-2032)
  11. 7.3.2 Europe Fosfomycin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Fosfomycin Calcium Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Fosfomycin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Fosfomycin Calcium Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Fosfomycin Calcium Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Xinya Pharmaceutical
  2. 8.1.1 Shanghai Xinya Pharmaceutical Company Information
  3. 8.1.2 Shanghai Xinya Pharmaceutical Business Overview
  4. 8.1.3 Shanghai Xinya Pharmaceutical Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Xinya Pharmaceutical Fosfomycin Calcium Product Portfolio
  6. 8.1.5 Shanghai Xinya Pharmaceutical Recent Developments
  7. 8.2 Shanghai Wuzhou Pharmaceutical
  8. 8.2.1 Shanghai Wuzhou Pharmaceutical Company Information
  9. 8.2.2 Shanghai Wuzhou Pharmaceutical Business Overview
  10. 8.2.3 Shanghai Wuzhou Pharmaceutical Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Wuzhou Pharmaceutical Fosfomycin Calcium Product Portfolio
  12. 8.2.5 Shanghai Wuzhou Pharmaceutical Recent Developments
  13. 8.3 Merck KGaA
  14. 8.3.1 Merck KGaA Company Information
  15. 8.3.2 Merck KGaA Business Overview
  16. 8.3.3 Merck KGaA Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck KGaA Fosfomycin Calcium Product Portfolio
  18. 8.3.5 Merck KGaA Recent Developments
  19. 8.4 Hubei Xunda Pharmaceutical
  20. 8.4.1 Hubei Xunda Pharmaceutical Company Information
  21. 8.4.2 Hubei Xunda Pharmaceutical Business Overview
  22. 8.4.3 Hubei Xunda Pharmaceutical Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hubei Xunda Pharmaceutical Fosfomycin Calcium Product Portfolio
  24. 8.4.5 Hubei Xunda Pharmaceutical Recent Developments
  25. 8.5 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd.
  26. 8.5.1 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Fosfomycin Calcium Product Portfolio
  30. 8.5.5 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Guangxi Nanning Baihui Pharmaceutical
  32. 8.6.1 Guangxi Nanning Baihui Pharmaceutical Company Information
  33. 8.6.2 Guangxi Nanning Baihui Pharmaceutical Business Overview
  34. 8.6.3 Guangxi Nanning Baihui Pharmaceutical Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Guangxi Nanning Baihui Pharmaceutical Fosfomycin Calcium Product Portfolio
  36. 8.6.5 Guangxi Nanning Baihui Pharmaceutical Recent Developments
  37. 8.7 Shanxi Dongjin Pharmaceutical Co., Ltd.
  38. 8.7.1 Shanxi Dongjin Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Shanxi Dongjin Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Shanxi Dongjin Pharmaceutical Co., Ltd. Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanxi Dongjin Pharmaceutical Co., Ltd. Fosfomycin Calcium Product Portfolio
  42. 8.7.5 Shanxi Dongjin Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Shinpoong Pharm
  44. 8.8.1 Shinpoong Pharm Company Information
  45. 8.8.2 Shinpoong Pharm Business Overview
  46. 8.8.3 Shinpoong Pharm Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shinpoong Pharm Fosfomycin Calcium Product Portfolio
  48. 8.8.5 Shinpoong Pharm Recent Developments
  49. 8.9 Northeast Pharm
  50. 8.9.1 Northeast Pharm Company Information
  51. 8.9.2 Northeast Pharm Business Overview
  52. 8.9.3 Northeast Pharm Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Northeast Pharm Fosfomycin Calcium Product Portfolio
  54. 8.9.5 Northeast Pharm Recent Developments
  55. 8.10 Manus Aktteva Biopharma LLP
  56. 8.10.1 Manus Aktteva Biopharma LLP Company Information
  57. 8.10.2 Manus Aktteva Biopharma LLP Business Overview
  58. 8.10.3 Manus Aktteva Biopharma LLP Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Manus Aktteva Biopharma LLP Fosfomycin Calcium Product Portfolio
  60. 8.10.5 Manus Aktteva Biopharma LLP Recent Developments
  61. 8.11 FarmaSino Pharmaceutical
  62. 8.11.1 FarmaSino Pharmaceutical Company Information
  63. 8.11.2 FarmaSino Pharmaceutical Business Overview
  64. 8.11.3 FarmaSino Pharmaceutical Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 FarmaSino Pharmaceutical Fosfomycin Calcium Product Portfolio
  66. 8.11.5 FarmaSino Pharmaceutical Recent Developments
  67. 8.12 Ercros
  68. 8.12.1 Ercros Company Information
  69. 8.12.2 Ercros Business Overview
  70. 8.12.3 Ercros Fosfomycin Calcium Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ercros Fosfomycin Calcium Product Portfolio
  72. 8.12.5 Ercros Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Fosfomycin Calcium Value Chain Analysis
  2. 9.1.1 Fosfomycin Calcium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Fosfomycin Calcium Production Mode & Process
  6. 9.2 Fosfomycin Calcium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Fosfomycin Calcium Distributors
  9. 9.2.3 Fosfomycin Calcium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.